dc.contributor.author |
Chuquiyauri, Raul |
|
dc.contributor.author |
Peñataro, Pablo |
|
dc.contributor.author |
Brouwer, Kimberly C. |
|
dc.contributor.author |
Fasabi, Manuel |
|
dc.contributor.author |
Calderón Sánchez, Maritza Mercedes |
|
dc.contributor.author |
Torres, Sonia |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.contributor.author |
Kosek, Margaret |
|
dc.contributor.author |
Vinetz, Joseph Michael |
|
dc.date.accessioned |
2022-01-04T20:33:21Z |
|
dc.date.available |
2022-01-04T20:33:21Z |
|
dc.date.issued |
2013 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/10768 |
|
dc.description.abstract |
To determine the magnitude of Plasmodium vivax relapsing malaria in rural Amazonia, we carried out a study in four sites in northeastern Peru. Polymerase chain reaction-restriction fragment length polymorphism of PvMSP-3α and tandem repeat (TR) markers were compared for their ability to distinguish relapse versus reinfection. Of 1,507 subjects with P. vivax malaria, 354 developed > 1 episode during the study; 97 of 354 (27.5%) were defined as relapse using Pvmsp-3α alone. The addition of TR polymorphism analysis significantly reduced the number of definitively defined relapses to 26 of 354 (7.4%) (P < 0.05). Multivariate logistic regression modeling showed that the probability of having > 1 infection was associated with the following: subjects in Mazan (odds ratio [OR] = 2.56; 95% confidence interval [CI] 1.87, 3.51), 15–44 years of age (OR = 1.49; 95% CI 1.03, 2.15), traveling for job purposes (OR = 1.45; 95%CI 1.03, 2.06), and travel within past month (OR = 1.46; 95% CI 1.0, 2.14). The high discriminatory capacity of the molecular tools shown here is useful for understanding the micro-geography of malaria transmission. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
American Society of Tropical Medicine and Hygiene |
|
dc.relation.ispartofseries |
American Journal of Tropical Medicine and Hygiene |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.subject |
Geographical variation (species) |
en_US |
dc.subject |
major clinical study |
en_US |
dc.subject |
Peru |
en_US |
dc.subject |
polymerase chain reaction |
en_US |
dc.subject |
disease association |
en_US |
dc.subject |
Time Factors |
en_US |
dc.subject |
DNA, Protozoan |
en_US |
dc.subject |
disease transmission |
en_US |
dc.subject |
Plasmodium vivax |
en_US |
dc.subject |
Plasmodium vivax malaria |
en_US |
dc.subject |
Polymerase Chain Reaction |
en_US |
dc.subject |
Genetic Markers |
en_US |
dc.subject |
Genotype |
en_US |
dc.subject |
Molecular Epidemiology |
en_US |
dc.subject |
probability |
en_US |
dc.subject |
Recurrence |
en_US |
dc.subject |
Polymorphism, Genetic |
en_US |
dc.subject |
Protozoan Proteins |
en_US |
dc.subject |
chloroquine plus primaquine |
en_US |
dc.subject |
travel |
en_US |
dc.subject |
reinfection |
en_US |
dc.subject |
Polymorphism, Restriction Fragment Length |
en_US |
dc.subject |
restriction fragment length polymorphism |
en_US |
dc.subject |
tandem repeat |
en_US |
dc.title |
Microgeographical differences of Plasmodium vivax relapse and re-infection in the Peruvian Amazon |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.4269/ajtmh.13-0060 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.06 |
|
dc.relation.issn |
1476-1645 |
|